Business Context and Reporting Period
The filing identifies the registrant as Ambac Financial Group, Inc., not OCTAVE SPECIALTY GROUP INC. This Form 10-Q covers the quarter and six months ended June 30, 2014. Ambac is a financial services holding company with Financial Guarantee and Financial Services segments. It emerged from Chapter 11 on May 1, 2013 and adopted fresh-start accounting, so 2014 Successor results are not directly comparable with 2013 Predecessor results.
The financial guarantee business is in runoff and Ambac Assurance cannot currently write new business. The Financial Services businesses are also in active runoff. Management states that substantial doubt exists regarding Ambac’s ability to continue as a going concern, although the financial statements were prepared on a going-concern basis.
Key Financial Metrics
| Metric | Three months ended June 30, 2014 | Six months ended June 30, 2014 |
|---|---|---|
| Net premiums earned | $65.0 million | $147.6 million |
| Net investment income | $80.1 million | $150.9 million |
| Total revenues before expenses and reorganization items | $57.3 million | $166.5 million |
| Losses and loss expenses | $175.3 million | $35.3 million |
| Pre-tax loss from continuing operations | $210.4 million | $51.1 million |
| Net loss attributable to common shareholders | $207.9 million | $52.0 million |
| Loss per common share | $4.61 | $1.15 |
| Operating earnings (losses), non-GAAP | $(113.3) million | $63.3 million |
- Balance sheet: Total assets were $27.7 billion, total liabilities were $26.5 billion, and total stockholders’ equity was $1.2 billion at June 30, 2014.
- Liquidity: Cash and cash equivalents were $74.5 million. Operating activities provided $172.3 million of cash during the first six months, investing activities provided $14.8 million, and financing activities used $190.0 million, primarily for investment agreement draws.
- Investments: Total investments were $6.8 billion, including $6.1 billion of fixed-income securities and $344.2 million of short-term investments.
- Debt and obligations: Long-term debt was $981.4 million, excluding $14.5 billion of consolidated variable-interest-entity debt. Obligations under investment agreements were $169.6 million.
- Insurance reserves: Gross loss and loss expense reserves were $5.6 billion, including $3.2 billion of unpaid claims, $308.1 million of accrued interest on Deferred Amounts, and $4.5 billion of present value of expected net claims and expenses, offset by recoveries and unearned premiums.
- Exposure: Guaranteed net par outstanding was $167.7 billion, comprising $108.4 billion of public finance, $28.9 billion of structured finance, and $30.4 billion of international finance exposure.
Material Changes Versus Comparable 2013 Periods
- Quarterly net loss attributable to common shareholders was $207.9 million in 2014 versus $205.7 million of income in the May-June 2013 Successor period. The comparison is materially distorted by fresh-start accounting and different reporting periods.
- Six-month net loss attributable to common shareholders was $52.0 million in 2014 versus $3.35 billion of income in the January-April 2013 Predecessor period, which included approximately $2.75 billion of reorganization gains from debt cancellation and fresh-start adjustments.
- Quarterly revenue declined from $242.4 million in the May-June 2013 Successor period to $57.3 million. Major unfavorable movements included derivative product revenue, which declined to a $48.0 million loss, and variable-interest-entity results, which declined to a $38.1 million loss.
- Losses and loss expenses increased substantially in the quarter, principally because $308.1 million of interest on Deferred Amounts was recognized under the amended Segregated Account Rehabilitation Plan. This was partly offset by favorable RMBS development.
- Net investment income increased to $80.1 million for the quarter and $150.9 million for the six months, supported by investment in Ambac-wrapped securities and improved performance of certain holdings.
- Guaranteed net par outstanding declined from $179.1 billion at December 31, 2013 to $167.7 billion at June 30, 2014, reflecting portfolio runoff, amortization, claims and other reductions.
- Accumulated other comprehensive income increased from $11.7 million at December 31, 2013 to $306.3 million at June 30, 2014, primarily from unrealized investment gains.
- Adjusted Book Value, a non-GAAP measure, declined from negative $280.7 million to negative $351.5 million, primarily because of a reduction in net unearned premiums and fees in excess of expected losses.
Guidance, Outlook, Commentary and Risks
- The Segregated Account rehabilitation plan was amended effective June 12, 2014. Initial cash payments on permitted policy claims increased from 25% to 45% beginning July 21, 2014; unpaid balances generally become Deferred Amounts accruing compound interest at an effective annual rate of 5.1%.
- On December 22, 2014, the Rehabilitator expected to make equalizing payments on Deferred Amounts estimated at approximately $1.14 billion based on June 30 balances. Related early redemptions of third-party surplus notes were estimated at approximately $413.6 million. Management stated that total future cash outflows associated with these payments and redemptions were expected to exceed $1.5 billion.
- Ambac Assurance’s policyholder surplus was $945.7 million at June 30, 2014, above the $100 million minimum surplus amount. However, the Rehabilitator controls the Segregated Account and acts for policyholders rather than Ambac securityholders.
- Ambac Assurance has not paid dividends to Ambac for the foreseeable future, materially limiting parent-company liquidity. Surplus-note interest payments require regulatory approval and had not been paid since issuance.
- Ambac UK reported a shareholder-funds deficit of £112.0 million under UK GAAP and a regulatory capital shortfall of £422.0 million. Regulatory discussions were ongoing and available options were described as limited.
- Management identified significant reserve sensitivity. Reasonably possible additional loss reserves were approximately $171 million for RMBS, $636 million for student loans, $1.755 billion for public finance, and $918 million for other credits including Ambac UK.
- Key risks include the going-concern uncertainty, rehabilitation and regulatory actions, payment timing and amount of Deferred Amounts, public-finance and Puerto Rico credit deterioration, RMBS and student-loan losses, collectability of approximately $2.3 billion of estimated RMBS subrogation recoveries, litigation, interest-rate and spread volatility, collateral requirements, derivative termination rights, and possible additional impairment charges.
- Ambac states that its disclosure controls and procedures were effective as of June 30, 2014, with no material change in internal control over financial reporting during the period.
Important Facts for Investors to Verify
- Confirm the correct registrant: the supplied filing is for Ambac Financial Group, Inc., while the request metadata names OCTAVE SPECIALTY GROUP INC.
- Assess the effect of fresh-start accounting and the Successor/Predecessor presentation before comparing 2014 results with 2013.
- Verify the funding sources and timing for the expected December 2014 Deferred Amount and surplus-note payments exceeding $1.5 billion.
- Review Ambac Assurance’s statutory surplus, dividend restrictions, surplus-note obligations, and the potential for further rehabilitation proceedings.
- Evaluate the supportability of loss reserves and subrogation recoveries, particularly the stated stress-case exposure for public finance, student loans, RMBS and Ambac UK.
- Review the liquidity impact of runoff, investment agreement withdrawals, collateral requirements, derivative termination rights and the absence of parent-level dividends.
- Distinguish GAAP net loss from non-GAAP Operating Earnings and negative Adjusted Book Value when assessing underlying economics.